Clostridioides difficile infection in the allogeneic hematopoietic cell transplant recipient. (https://dx.doi.org/10.1111/tid.14159)
Microbiome profile and calprotectin levels as markers of risk of recurrent Clostridioides difficile infection. (https://dx.doi.org/10.3389/fcimb.2023.1237500)
Two Times Versus Four Times Daily Cephalexin Dosing for the Treatment of Uncomplicated Urinary Tract Infections in Females. (https://dx.doi.org/10.1093/ofid/ofad430)
Effects of fecal microbiota transplantation for recurrent Clostridium difficile infection in children on kidney replacement therapy: a pilot study. (https://dx.doi.org/10.1007/s00467-023-06168-6)
Antisense inhibition of RNA polymerase Î± subunit of Clostridioides difficile. (https://dx.doi.org/10.1128/spectrum.01755-23)
Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection. (https://dx.doi.org/10.1017/ash.2023.435)
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice. (https://dx.doi.org/10.57187/smw.2023.40100)
Atypical presentation of a rare disorder; idiopathic myointimal hyperplasia of mesenteric veins (IMHMV): Report of two cases. (https://dx.doi.org/10.1016/j.ijscr.2023.108839)
Biofilm Formation of Clostridioides difficile, Toxin Production and Alternatives to Conventional Antibiotics in the Treatment of CDI. (https://dx.doi.org/10.3390/microorganisms11092161)
Prevalence of Non-Toxigenic Clostridioides difficile in Diarrhoea Patients and Their Clinical Characteristics. (https://dx.doi.org/10.3390/antibiotics12091360)
Safety and tolerability of frozen, capsulized autologous faecal microbiota transplantation. A randomized double blinded phase I clinical trial. (https://dx.doi.org/10.1371/journal.pone.0292132)
The Intestinal Microbiome and the Metabolic Syndrome-How Its Manipulation May Affect Metabolic-Associated Fatty Liver Disease (MAFLD). (https://dx.doi.org/10.3390/cimb45090455)
Clostridium scindens secretome suppresses virulence gene expression of Clostridioides difficile in a bile acid-independent manner. (https://dx.doi.org/10.1128/spectrum.03933-22)
Correlation between the presence of a cecal appendix and reduced diarrhea severity in primates: new insights into the presumed function of the appendix. (https://dx.doi.org/10.1038/s41598-023-43070-5)
Short-course empiric antibiotics in children undergoing allogeneic hematopoietic cell transplant. (https://dx.doi.org/10.1016/j.jtct.2023.09.011)
Long-term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data over Eight Years from the Hong Kong FMT Registry. (https://dx.doi.org/10.1016/j.cgh.2023.09.001)
A Potent and Narrow-Spectrum Antibacterial against Clostridioides difficile Infection. (https://dx.doi.org/10.1021/acs.jmedchem.3c01249)
Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo. (https://dx.doi.org/10.4291/wjgp.v14.i4.71)
A Combined Surgical Approach for Recurrent Patellar Dislocation in Adolescents with Patella Alta and Increased Tibial Tuberosity-Trochlear Groove Distance: Improved Clinical Outcomes but Decreased Posterior Tibial Slopes in Skeletally Immature Patients at Minimum 4-Year Follow-up. (https://dx.doi.org/10.1016/j.arthro.2023.09.001)
Evaluation of the effectiveness and safety of oral vancomycin versus placebo in the prevention of recurrence of Clostridioides difficile infection in patients under systemic antibiotic therapy: a phase III, randomised, double-blind clinical trial. (https://dx.doi.org/10.1136/bmjopen-2023-072121)
